ALI HEALTH (00241.HK) 0.000 (0.000%) Short selling $153.16M; Ratio 34.469% announced its FY2026 results, with revenue of RMB34.26 billion, up 12% YoY, CICC said in its report. Non-GAAP net profit amounted to RMB2.33 billion, up 19.3% YoY, corresponding to a margin of 6.8%, up 0.4 ppts YoY, weaker than the broker's expectations, owing to higher-than-expected investment expenses in new strategic business directions. Considering that the company may further step up investment in strategic initiatives, CICC axed its FY2027 non-GAAP net profit forecast by 15% to RMB2.33 billion, and introduced a FY2028 non-GAAP net profit forecast of RMB2.57 billion for the first time. Related NewsCiti Cuts ALI HEALTH (00241.HK) TP to HKD8, Remains Optimistic Long TermGiven the company's solid long-term competitiveness as an industry leader and the valuation rollover to FY2027, CICC trimmed its FY2027 TP by 8.5% to HKD6.5, while maintaining an Outperform rating. (HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-22 16:25.)
AASTOCKS Financial News